Qilin ransomware hit Inotiv (pharmaceutical research) in August 2025, driving costs past $2.48M in Q4 and $5.93M for fiscal year. Company faces consolidated class action lawsuits alleging inadequate security and delayed notification. Attackers stole 176GB, published on darkweb after ransom timer expired. Breach affected 9,542 individuals—employees, family, people who interacted with Inotiv. Attack caused business disruptions and production shutdowns. Still evaluating full impact. Offering 24-month credit monitoring. Discovered August 8, attackers accessed systems August 5-8. Revenue: $513M in fiscal 2025. Works on drug discovery across cardiovascular, neuroscience, oncology, infectious diseases.

📂 Incident

Qilin Ransomware Hits Inotiv, Driving Millions in Costs and Lawsuits